Advertisement

Gastroenterologia Japonica

, Volume 21, Issue 6, pp 617–622 | Cite as

Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome

  • Itsuro Nakano
  • Akihiro Funakoshi
  • Toshinari Kimura
  • Yasuji Miyata
  • Shunichi Koga
  • Hiroshi Ibayashi
Original Article
  • 7 Downloads

Summary

Serum pancreatic secretory trypsin inhibitor (PSTI) was measured by radioimmunoassay in 5 patients with malabsorption syndrome. The serum level of PSTI was elevated to 123.8 ±25.8 ng/ml (Mean ±SE) in patients with malabsorption syndrome, which was significantly higher than the 16.6 ±0.7 ng/ml level seen in 116 healthy control subjects. Serum PSTI levels in 5 patients with malabsorption syndrome showed inverse correlations with serum levels of cholesterol, cholinesterase and amylase, and not with serum levels of vitamin E, carotene, apoprotein A-IV, albumin, nor with immunoreactive elastase 1, respectively. These results suggest that elevated levels of serum PSTI represent a state of malnutrition due to impaired intestinal absorption.

Key words

Pancreatic secretory trypsin inhibitor (PSTI) Malabsorption syndrome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Kazal LA, et al: Isolation of a crystalline trypsin inhibitor—Anticoagulant protein from pancreas. J Am Chem Soc 70: 3034, 1948CrossRefPubMedGoogle Scholar
  2. 2).
    Greene LJ, et al: Human pancreatic secretory trypsin inhibitor. Meth Enzymol 45: 813, 1976PubMedGoogle Scholar
  3. 3).
    Eddeland A, et al: A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids. Hoppe-Seyler’s Z Physiol Chem 359: 671, 1978PubMedGoogle Scholar
  4. 4).
    Kitahara T, et al: Radioimmunoassay for human pancreatic secretory trypsin inhibitor: Measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases. Clin Chem Acta 103: 135, 1980CrossRefGoogle Scholar
  5. 5).
    Nakano I, et al: Clinical study on measurement of serum immunoreactive pancreatic trypsin inhibitor (PSTI). Clinical Endocrinology 32: 255, 1984 (Jpn)Google Scholar
  6. 6).
    Davies JNP: The essential pathology of kwashiorkor. Lancet 1: 317, 1948CrossRefPubMedGoogle Scholar
  7. 7).
    Veghelyi PV, et al: Dietary lesions of the pancreas. Am J Dis Child 79: 658, 1950Google Scholar
  8. 8).
    Thompson MD, et al: Pancreatic enzyme activity in duodenal contents of children with a type of kwashiorkor. Lancet 1: 1031, 1952PubMedCrossRefGoogle Scholar
  9. 9).
    Owyang C, et al: Colonic inhibition of pancreatic and biliary secretion. Gastroenterology 84: 470, 1983PubMedGoogle Scholar
  10. 10).
    Abe K, et al: Fluorometric quantitation of serum tocopherol. Nutrition and Food 28: 277, 1975 (Jpn)Google Scholar
  11. 11).
    Hashim SA, et al: Rapid determination of tocopherol in macro- and microquantities of plasma. Results obtained in various nutrition and metabolic studies. Am J Clin Nutr 19: 137, 1966PubMedGoogle Scholar
  12. 12).
    Koga S, et al: Plasma apoprotein A-IV levels decrease in patients with chronic pancreatitis and malabsorption syndrome. Digestion 32: 19, 1985PubMedCrossRefGoogle Scholar
  13. 13).
    Matsumoto M: A study on vitamin E in chronic pancreatitis. Jpn J Gastroenterol 79: 1147, 1982 (Jpn)Google Scholar
  14. 14).
    Scheving LA: Primary aminoacid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family. Arch Biochem Biophys 226: 411, 1983PubMedCrossRefGoogle Scholar
  15. 15).
    Yamamoto T, et al: Proceedings of Japan Pancreas Society 15: 134, 1985 (Jpn)Google Scholar
  16. 16).
    Rifkin DB, et al: Isolation of a protease inhibitor from tissues resistant to tumor invasion. Hoppe-Seyler’s Z Physiol Chem 358: 1525, 1977PubMedGoogle Scholar
  17. 17).
    Huhtala ML, et al: Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 257: 13713, 1982PubMedGoogle Scholar
  18. 18).
    Matsuda K, et al: Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res Comm Chem Pathol Pharmacol 40: 301, 1983Google Scholar
  19. 19).
    Fushiki T, et al: Stimulatory effect of an endogenous peptide in rat pancreatic juice on pancreatic enzyme secretion on the presence of atropine: Evidence for different mode of action of stimulation from exogenous trypsin inhibitors. Biochem Biophys Res Commun 118: 532, 1984PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1986

Authors and Affiliations

  • Itsuro Nakano
    • 1
  • Akihiro Funakoshi
    • 1
  • Toshinari Kimura
    • 1
  • Yasuji Miyata
    • 1
  • Shunichi Koga
    • 1
  • Hiroshi Ibayashi
    • 1
  1. 1.The Third Department of Internal MedicineKyushu UniversityFukuokaJapan

Personalised recommendations